A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02106364
Recruitment Status : Withdrawn (Lilly's decision to cancel this trial is due to regulatory uncertainty in China.)
First Posted : April 8, 2014
Last Update Posted : March 28, 2016
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : November 2015
  Estimated Study Completion Date : June 2016